Colorectal Cancer and Peritoneal Metastases
Clinical research activity is centered on colorectal cancer with a specific focus on peritoneal metastases, addressing disease spread within the abdominal cavity and its surgical management.
- Colon cancer
- Peritoneal recurrence
- Abdominal metastatic disease
The sponsor’s trial portfolio in this area reflects interest in outcomes after surgical debulking and the control of metastatic disease confined to the peritoneum.
Hyperthermic Intraoperative Chemotherapy
Research includes the use of HIPEC with Mitomycin-C in patients undergoing surgical treatment for peritoneal metastases of colon cancer.
- HIPEC
- Mitomycin-C
- Intraoperative chemotherapy
This area is directed toward evaluating locoregional treatment strategies in combination with complete resection of visible disease.
Surgical Oncology
The sponsor is involved in oncologic surgery for patients with advanced colon cancer, with attention to complete surgical resection and management of residual microscopic disease.
- Surgical debulking
- Complete resection
- Peritoneal disease control
Clinical interest extends to postoperative recurrence patterns after aggressive local treatment of metastatic abdominal disease.
Multicentre Clinical Research
Trial activity is carried out through a multicentre network involving collaborating research sites across Spain, supporting coordinated evaluation of surgical and intraperitoneal treatment approaches.
- Collaborative hospital network
- Clinical oncology
- Peritoneal cancer care
The research setting is rooted in hospital-based care for patients with complex metastatic gastrointestinal cancer.
